Pediatric Endocrinology Diabetes and Metabolism

Skuteczność leczenia rekombinowanym hormonem wzrostu u dzieci urodzonych jako za małe w stosunku do wieku ciążowego (SGA) – analiza retrospektywna

  1. Department of Paediatrics and Endocrinology, Medical University of Warsaw, Poland

Pediatr Endocrinol Diabetes Metab 2026; 32 (3):

Data publikacji online: 2026/08/07
Plik artykułu
0420_Efficacy of recombinant.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Bręborowicz GH, ed. Położnictwo i ginekologia. T. I–II. Warszawa: Wydawnictwo Lekarskie PZWL; 2008.
  2. Hwang IT. Efficacy and safety of growth hormone treatment for children born small for gestational age: a systematic review and meta-analysis. Korean J Pediatr 2014; 57: 379–383. doi: 10.3345/kjp.2014.57.9.379.
  3. Kum CD, Rho JG, Park HK, et al. Factors influencing growth hormone therapy effect during short stature in children born small for gestational age. Ann Pediatr Endocrinol Metab 2021;26: 31–37. doi: 10.6065/apem.2040096.048.
  4. Juul A, Backeljauw P, Cappa M, et al. Early growth hormone initiation leads to favorable long-term outcomes in children born small for gestational age. J Clin Endocrinol Metab 2023; 108: 1043–1052. doi: 10.1210/clinem/dgac694.
  5. Lem AJ, van der Kaay DCM, de Ridder MAJ, et al. Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial. J Clin Endocrinol Metab 2012; 97: 4096–4105.
  6. Kamoun C, Hawkes CP, Gunturi H, et al. Growth hormone stimulation testing patterns contribute to sex differences in pediatric growth hormone treatment. Horm Res Paediatr 2021; 94: 353–363. doi: 10.1159/000520250.
  7. Sävendahl L, Blankenstein O, Oliver I, et al. Gender influences short-term growth hormone treatment response in children. Horm Res Paediatr 2012; 77: 188–194. doi: 10.1159/000337570.
  8. Horikawa R, Tanaka T, Nishinaga H, et al. The long-term safety and effectiveness of growth hormone treatment in children born small for gestational age. Clin Pediatr Endocrinol 2020; 29: 159–171. doi: 10.1297/cpe.29.159.
  9. Smeets CCJ, Renes JS, van der Steen M, Hokken-Koelega ACS. Metabolic health and long-term safety of growth hormone treatment in Silver-Russell syndrome. J Clin Endocrinol Metab 2017; 102: 983–991. doi: 10.1210/jc.2016-3388.
Udostępnij
without publication fees